Goldstein Michael H.
SEC CIK 1691259 · EDGAR
Companies
| Ticker | Company | Title | Holding | Bought | Sold | Trades | First | Last |
|---|---|---|---|---|---|---|---|---|
| OCUL | OCULAR THERAPEUTIX, INC | Pres, CMO, Ophthalmology | 313.3K | — | — | 1 | 2022-02-03 | 2022-02-03 |
Most active insiders at OCUL, 12 months
| # | Insider | Title | Bought | Sold |
|---|---|---|---|---|
| 1 | Dugel Pravin | See Remarks, Dir | — | $1.94M |
| 2 | LINDSTROM RICHARD L MD | Dir | $461.4K | — |
| 3 | Saroj Namrata | Chief Business Off | — | $277.8K |
| 4 | Heier Jeffrey S. | CSO | — | $243.3K |
| 5 | Kaiser Peter | Chief Development Off | — | $222.9K |
| 6 | Waheed Nadia | Chief Medical Off | — | $220.9K |
| 7 | Notman Donald | See Remarks | — | $216.1K |
| 8 | Nayak Sanjay | Chief Strategy Off | — | $166.4K |
| 9 | Anderman Todd | CLO | — | $137.4K |
| 10 | Robinson David Wayne | Gbl CCO | — | — |
Goldstein Michael H. made no open-market trades at OCUL in the last 12 months.
Transactions 1
| X | Filed | Traded | Ticker | Company | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| D | 2022-02-07 | 2022-02-03 | OCUL | OCULAR THERAPEUTIX, INC | Goldstein Michael H. | Pres, CMO, Ophthalmology | A - Grant | $0.00 | +63.3K | 313.3K | +25% | $0 |
Purchase Sale Sale after option exercise All abbreviations